Glypressin
Glypressin contains Terlipressin, a synthetic vasopressin analogue. It causes vasoconstriction of splanchnic vessels, lowering portal venous pressure to control variceal bleeding and improve renal perfusion in hepatorenal syndrome.
Dosage by Body Weight
For intravenous injection only. Must be administered by a healthcare professional in a hospital setting. Adult dose for esophageal varices is typically 1 to 2 mg IV initially, then 1 to 2 mg every 4 to 6 hours until bleeding is controlled.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- None
- Tracking Notes
- Safety and efficacy have not been established in children.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- None
- Tracking Notes
- Safety and efficacy have not been established in children.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- None
- Tracking Notes
- Safety and efficacy have not been established in children.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- None
- Tracking Notes
- Safety and efficacy have not been established in children.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- None
- Tracking Notes
- Safety and efficacy have not been established in children.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | None | Safety and efficacy have not been established in children. |
| 5-7 kg | Not recommended | None | Safety and efficacy have not been established in children. |
| 8-10 kg | Not recommended | None | Safety and efficacy have not been established in children. |
| 11-15 kg | Not recommended | None | Safety and efficacy have not been established in children. |
| 16-20 kg | Not recommended | None | Safety and efficacy have not been established in children. |
Formulation
Injection
Purpose
Treatment of acute bleeding esophageal varices and hepatorenal syndrome (type 1).
Generic Name
TerlipressinScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.